SNWV vs XTNT vs NVCR vs MMSI

For growth investors, SANUWAVE Health, Inc.

(SNWV) is the stronger pick with 60. 0% revenue growth year-over-year, versus 8. 3% for NovoCure Limited (NVCR). Merit Medical Systems, Inc. (MMSI) offers the better valuation at 29. 3x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate SANUWAVE Health, Inc. (SNWV) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Merit Medical Systems, Inc.

is actually cheaper at 15. 1x.

Over the past 5 years, Merit Medical Systems, Inc.

(MMSI) delivered a total return of -3. 6%, compared to -91. 3% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: MMSI returned +209. 3% versus XTNT's -98. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Merit Medical Systems, Inc.

(MMSI) is the lower-risk stock at 0. 66β versus NovoCure Limited's 2. 15β — meaning NVCR is approximately 224% more volatile than MMSI relative to the S&P 500. On balance sheet safety, Merit Medical Systems, Inc. (MMSI) carries a lower debt/equity ratio of 57% versus 85% for NovoCure Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), SANUWAVE Health, Inc.

(SNWV) is pulling ahead at 60. 0% versus 8. 3% for NovoCure Limited (NVCR). On earnings-per-share growth, the picture is similar: SANUWAVE Health, Inc. grew EPS 42. 3% year-over-year, compared to 4. 9% for Merit Medical Systems, Inc.. Over a 3-year CAGR, SNWV leads at 35. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Merit Medical Systems, Inc.

(MMSI) is the more profitable company, earning 8. 5% net margin versus -96. 1% for SANUWAVE Health, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SNWV leads at 16. 6% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — SNWV leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Merit Medical Systems, Inc.

(MMSI) trades at 15. 1x forward P/E versus 42. 1x for SANUWAVE Health, Inc. — 27. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SNWV: 224. 3% to $54. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Merit Medical Systems, Inc.

(MMSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 66), +209. 3% 10Y return). NovoCure Limited (NVCR) carries a higher beta of 2. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MMSI: +209. 3%, NVCR: +38. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SNWV is a small-cap high-growth stock; XTNT is a small-cap high-growth stock; NVCR is a small-cap quality compounder stock; MMSI is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.